Why Attend

ICTO 2017 has assembled an international faculty of experts in the field of clinical investigation.

The congress will focus on areas including:
  • Design of clinical trials in the new era
  • Personalized cancer medicine
  • Immuno-oncology - End Point with Immunotherapy
  • Monitoring of Trials and Statistics
  • Regulations – Survival based Medicine
  • Phase 4 Trials
  • Expanded access trials
  • Ethics and Patients’ Rights
  • Healthcare economy
  • How to design a Clinical Trial
  • End Point with Immunotherapy
  • Side Effects
Be part of the Congress that will be a forerunner in analysis, interpretation and translation of data and knowledge relating to Clinical Trials in Oncology and Hemato-Oncology.

Join us in London to learn more!